Additionally, because injections bypass the digestive system, they are not subject to the exact breakdown and loss of potency that can occur during digestion
However, because AOD9604 is often selfadministered outside clinical settings, the safety margin can vary depending on sourcing, dosing accuracy, and overall protocol design
The standard approach starts at 2.5mg weekly for four weeks, then escalates in 2.5mg increments every four weeks based on tolerance and response
Subcutaneous (SC) : Common sites include the upper arm, thigh, or abdomen
Persistent effects beyond two weeks suggest considering dose reduction
Left untreated, a B12 deficiency can also lead to long-term health issues